Novavax (NVAX) Other Non-Current Assets (2010 - 2026)

Novavax's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $16.0 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 27.18% year-over-year to $16.0 million in Q1 2026; TTM through Mar 2026 was $16.0 million, a 27.18% decrease from a year earlier, with the FY2025 full-year figure at $87.5 million, up 264.62% from the prior year.
• Other Non-Current Assets slipped to $16.0 million in Q1 2026 per NVAX's latest filing, from $87.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $107.7 million in Q3 2025 and bottomed at $16.0 million in Q1 2026.
• The 5-year median for Other Non-Current Assets is $30.5 million (2023), against an average of $34.8 million.
• Biggest YoY gain for Other Non-Current Assets was 1213.83% in 2022; the steepest drop was 54.6% in 2022.
• Year by year, Other Non-Current Assets stood at $28.5 million in 2022, then advanced by 23.5% to $35.2 million in 2023, then slumped by 31.74% to $24.0 million in 2024, then soared by 264.62% to $87.5 million in 2025, then tumbled by 81.77% to $16.0 million in 2026.
• Per Business Quant, the three latest NVAX Other Non-Current Assets figures stand at $16.0 million (Q1 2026), $87.5 million (Q4 2025), and $107.7 million (Q3 2025).